NCT03640247 is a Phase 1 clinical trial of Non-narcotic group regimen in Thyroid Disease, sponsored by MetroHealth Medical Center.

Who is sponsoring NCT03640247?

NCT03640247 is sponsored by MetroHealth Medical Center.

What drugs are being tested in NCT03640247?

Interventions in NCT03640247: Non-narcotic group regimen, Narcotic group regimen.

What condition does NCT03640247 study?

NCT03640247 studies Thyroid Disease, Parathyroid Diseases.

Is NCT03640247 still recruiting?

NCT03640247 is currently completed. Last updated 26 December 2019.

Last reviewed 2019-12-26 · How we verify

NCT03640247

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Medications Following Thyroidectomy and Parathyroidectomy

Completed Phase 1 Last updated 26 December 2019

What this trial tests

Phase 1 trial testing Non-narcotic group regimen in Thyroid Disease in 126 participants. Completed in 1 December 2019.

Timeline

15 November 2018

Primary endpoint
1 December 2019

1 December 2019

Quick facts

Lead sponsor	MetroHealth Medical Center
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	126
Start date	15 November 2018
Primary completion	1 December 2019
Estimated completion	1 December 2019
Sites	1 location across United States

Drugs / interventions tested

Non-narcotic group regimen — full drug profile →
Narcotic group regimen — full drug profile →

Conditions studied

Thyroid Disease — all drugs for Thyroid Disease →
Parathyroid Diseases — all drugs for Parathyroid Diseases →

Sponsor

MetroHealth Medical Center

Who can join

18 and older, any sex, with Thyroid Disease or Parathyroid Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Thyroid Disease

Currently open trials in the same condition.

NCT07354048 — Impact Of Thyroid Dysfunction on Liver Function Tests · recruiting
NCT07294989 — The Effective Blood Concentration of Ciprofol · recruiting
NCT06296420 — Dysphagia After Thyroidectomy · recruiting
NCT05117853 — Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy · Phase 3 · recruiting

Other MetroHealth Medical Center trials

Trials by the same sponsor.

NCT06734026 — Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury · NA · recruiting
NCT06664892 — Ultrahypofractionated Whole Breast Radiation Following Chemotherapy · NA · not yet recruiting
NCT06788795 — Effectiveness of a Wearable Hydration Device · Phase 2 · not yet recruiting
NCT06836739 — At-Home Genital Nerve Stimulation for SCI Bowel · NA · recruiting
NCT06113965 — Neural Operant Conditioning · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03640247 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MetroHealth Medical Center
Last refreshed: 26 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03640247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing